In focus · trending topic

superficial femoral artery

2 stories · following the connections

Proteon Therapeutics Announces Overview of Phase 1 Clinical Program of Investigational Vonapanitase in Peripheral Artery Disease to be Presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT) Conference

By Nasdaq OMXOct 25, 2016, 12:02 PM UTC

Proteon Therapeutics Announces Overview of Phase 1 Clinical Program of Investigational Vonapanitase in Peripheral Artery Disease to be Presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT) Conference

By Nasdaq OMXOct 25, 2016, 12:02 PM UTC